Delivery Order SPE2DB20D1100-SPE2DB24FD2W9
Award Date
8/15/24
Potential Completion Date
8/16/24
Potential Value
$7.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ozempic 0.25-0.5 mg/dose pen 3ml. The contract has a ceiling value of $11,533.04 and is a Firm Fixed Price Delivery Order running through December 17, 2024. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ozempic (0.25-0.5 mg/dose) pens. The contract is a Firm Fixed Price Delivery Order with a total ceiling value of $9,740.97 and an ultimate completion date of September 25, 2024. AmerisourceBergen, through its Corporate Office Division, has been awarded this contract to supply the DLA with this critical diabetes medication. This award...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,013.28 firm fixed price delivery order covers the supply of Ozempic 0.25-0.5 mg/dose pen 3 ml, a medication used for diabetes management. The contract has an ultimate completion date of January 21, 2025 and does not contain any set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ozempic 0.25-0.5 mg/dose pen 3 mL. The contract has a firm-fixed price of $7,328.68 and an ultimate completion date of January 12, 2024. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. (doing business as AmerisourceBergen) with the DLA Troop Support Medical, valued at up to...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $33,360.12, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of January 25, 2024. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,161.08 firm fixed price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pen 3 ml, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to support...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of Ozempic 0.25-0.5 mg/dose pens. The $4,508.61 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency. The contract has an ultimate completion date of July 31, 2024 and is not designated as a small business set-aside. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Ozempic 0.25-0.5 mg/dose pen 3 mL. The contract is a Firm Fixed Price Delivery Order valued at $13,804.48, with a period of performance through July 11, 2024. AmerisourceBergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 mL dosage. The award has a ceiling value of $33,990.49 and an ultimate completion date of November 17, 2023. It is a firm-fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ozempic 0.25-0.5 mg/dose pens. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,181.36 and an ultimate completion date of July 17, 2024. Amerisourcebergen, through its Corporate Office Division, will be providing these pharmaceutical products to support military treatment facilities and other government...